Results 1 to 10 of about 5,707,439 (181)

The tigecycline resistance mechanisms in Gram-negative bacilli [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology
Tigecycline, hailed as a pivotal agent in combating multidrug-resistant bacterial infections, confronts obstacles posed by the emergence of resistance mechanisms in Gram-negative bacilli.
Zhiren Wang, Zhiren Wang, Henan Li
doaj   +7 more sources

Molecular mechanisms of tigecycline-resistance among Enterobacterales [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology
The global emergence of antimicrobial resistance to multiple antibiotics has recently become a significant concern. Gram-negative bacteria, known for their ability to acquire mobile genetic elements such as plasmids, represent one of the most hazardous ...
Lukasz Korczak   +9 more
doaj   +7 more sources

Resistance mechanisms of tigecycline in Acinetobacter baumannii [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Acinetobacter baumannii is widely distributed in nature and in hospital settings and is a common pathogen causing various infectious diseases. Currently, the drug resistance rate of A.
Chunli Sun   +7 more
doaj   +6 more sources

Tigecycline Resistance-Associated Mutations in the MepA Efflux Pump in Staphylococcus aureus

open access: yesMicrobiology Spectrum, 2023
Tigecycline is an important antibacterial drug for treating infection by clinical multidrug-resistant bacteria, and tigecycline-resistant Staphylococcus aureus (TRSA) has been increasingly reported in recent years.
Honghao Huang   +6 more
doaj   +3 more sources

Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.

open access: yesPLoS ONE, 2015
KPC-producing Klebsiella pneumoniae isolates have emerged as important pathogens of nosocomial infections, and tigecycline is one of the antibiotics recommended for severe infections caused by KPC-producing K. pneumoniae.
Fang He   +6 more
doaj   +5 more sources

The first tigecycline resistant Enterococcus faecium in Norway was related to tigecycline exposure [PDF]

open access: yesJournal of Global Antimicrobial Resistance, 2023
: Objectives: We describe the first tigecycline resistant enterococcal isolate in Norway and the mechanisms involved. Material and methods: The Norwegian National Advisory Unit on Detection of Antimicrobial Resistance (K-res).
Kristin Hegstad   +4 more
doaj   +6 more sources

The Mechanism of Tigecycline Resistance in Acinetobacter baumannii under Sub-Minimal Inhibitory Concentrations of Tigecycline

open access: yesInternational Journal of Molecular Sciences
The presence of sub-minimal inhibitory concentration (sub-MIC) antibiotics in our environment is widespread, and their ability to induce antibiotic resistance is inevitable. Acinetobacter baumannii, a pathogen known for its strong ability to acquire antibiotic resistance, has recently shown clinical resistance to the last-line antibiotic tigecycline ...
Cunwei Liu   +4 more
core   +4 more sources

Evolution of tet(A) variant mediating tigecycline resistance in KPC-2-producing Klebsiella pneumoniae during tigecycline treatment

open access: yesJournal of Global Antimicrobial Resistance, 2022
: Objectives: This study investigated the underlying mechanism of the evolution of tigecycline resistance during treatment in a patient infected with Klebsiella pneumoniae harbouring blaKPC-2. Methods: A total of seven clonal K.
Wenli Liao   +8 more
doaj   +4 more sources

The Rapid Emergence of Tigecycline Resistance in blaKPC–2 Harboring Klebsiella pneumoniae, as Mediated in Vivo by Mutation in tetA During Tigecycline Treatment

open access: yesFrontiers in Microbiology, 2018
Tigecycline is one of the last resort treatments for carbapenem-resistant Klebsiella pneumoniae (CRKP) infections. Tigecycline resistance often occurs during the clinical treatment of CRKP, yet its mechanism has still not been clearly elucidated.
Xiaoxing Du   +6 more
doaj   +4 more sources

Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance

open access: yesInternational Journal of Antimicrobial Agents, 2016
During the past decades, rates of multidrug-resistant (MDR) and carbapenem-resistant (CR) Enterobacteriaceae clinical isolates, mainly Klebsiella spp., Escherichia coli, Enterobacter spp., Proteus spp. and Serratia marcescens, have increased, considerably restricting effective antimicrobial treatments.
Spyros Pournaras   +2 more
exaly   +6 more sources

Home - About - Disclaimer - Privacy